Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Director/PDMR Shareholding

10 Mar 2020 16:51

RNS Number : 6731F
Royal Bank of Scotland Group PLC
10 March 2020
 

10 March 2020

The Royal Bank of Scotland Group plc

 

 

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE EU MARKET ABUSE REGULATION 596/2014

 

 

1. The Royal Bank of Scotland Group plc (the Company) announces that conditional long term incentive (LTI) or deferred awards over ordinary shares of £1 each in the Company (Shares) (ISIN: GB00B7T77214), have been granted on 9 March 2020 under the RBS 2014 Employee Share Plan (the Plan) to the PDMRs set out below:-

 

Name of PDMR

Award

Position of PDMR

Maximum no. of

Shares eligible to vest

Vanessa Bailey

LTI

Chief Risk Officer, NatWest Holdings

411,451

Robert Begbie

Deferred

Interim CEO, NatWest Markets

258,626

 

Helen Cook

LTI

Chief HR Officer

529,008

Peter Flavel

Deferred

CEO, Private Banking

288,016

 

Bruce Fletcher

LTI

Chief Risk Officer, RBS Group

499,618

Andrew McLaughlin

LTI

CEO, RBS International

446,718

Simon McNamara

LTI

Chief Administrative Officer

587,786

Les Matheson

LTI

CEO, Personal Banking

587,786

Katie Murray

LTI

Chief Financial Officer

646,565

Alison Rose

LTI

Chief Executive Officer

881,679

John-Paul Thwaite

Deferred

CEO, Commercial Banking

199,848

 

 

The market price per Share used on the grant of the above awards was £1.701. The above transactions took place outside of a trading venue.

 

LTI awards were subject to a pre-grant performance assessment and a further performance assessment will take place at the end of three years. Subject to this pre-vest assessment, LTI awards will be eligible to vest between the years 2023 and 2027. Deferred awards will be eligible to vest between the years 2020 and 2027.

 

Malus provisions will apply up until vest and clawback provisions will apply for a period of seven years from the date of grant, extended to ten years, for relevant PDMRs, if events are under investigation at the end of the seven year period. Vested Shares retained after payment of associated tax liabilities will be subject to a twelve month retention period.

 

 

2. The Company announces that conditional LTI and deferred awards, including buy-outs, over Shares vested on 9 March 2020 to the PDMRs set out below. The awards were granted under the Plan between March 2015 and March 2019. The number of Shares withheld to meet associated tax liabilities arising on vesting and the number of vested Shares retained by each PDMR is set out below:-

 

Name of PDMR

Position of PDMR

Award

No. of Shares vested

No. of Shares withheld to satisfy associated tax liability

No. of vested Shares retained

Vanessa Bailey

Chief Risk Officer, NatWest Holdings

LTI

36,318

17,071

19,247

Deferred

12,693

5,966

6,727

Robert Begbie

Interim CEO, NatWest Markets

LTI

23,922

11,484

12,438

Deferred

64,200

30,818

33,382

Helen Cook

Chief HR Officer

LTI

19,368

9,104

10,264

Deferred

9,320

4,381

4,939

Peter Flavel

CEO, Private Banking

LTI

29,824

14,018

15,806

Deferred

41,278

19,402

21,876

Bruce Fletcher

Chief Risk Officer, RBS Group

Buy-out

68,033

31,976

36,057

Andrew McLaughlin1

CEO, RBS International

LTI

44,855

-

44,855

Deferred

80,466

-

80,466

Simon McNamara

Chief Administrative Officer

LTI

352,008

168,965

183,043

Les Matheson

CEO, Personal Banking

LTI

336,483

161,513

174,970

Katie Murray

Chief Financial Officer

LTI

9,143

4,298

4,845

Deferred

61,307

28,816

32,491

Alison Rose

Chief Executive Officer

LTI

422,920

198,774

224,146

John-Paul Thwaite

CEO, Commercial Banking

LTI

8,865

4,167

4,698

Deferred

47,799

22,467

25,332

1. The award was granted when the PDMR was resident in Jersey and therefore is taxable in Jersey only and not in the UK. No employer tax withholding is required under Jersey law. The Jersey income tax payable in respect of the vesting of the award will be paid by the PDMR directly to the Jersey tax authority.

 

The market price used to meet associated tax liabilities was £1.409. The above transactions took place outside of a trading venue.

 

Vested Shares retained after payment of associated tax liabilities will be subject to retention periods of between six and twelve months. For Mr Fletcher's awards, vested Shares, after payment of associated tax liabilities, will be subject to retention periods of between six and thirty months, in line with the original terms of his forfeited HSBC awards.

 

 

3. The Company announces that Shares were delivered to PDMRs on 9 March 2020, as set out below. The Shares delivered represent payment of a fixed share allowance for the three month period ending 31 March 2020 and have been calculated using a share price of £1.701.

 

The number of Shares delivered, the number of Shares withheld to meet associated tax liabilities and the number of Shares retained by each PDMR is as follows:-

 

Name of PDMR

Position of PDMR

No. of Shares delivered

No. of Shares withheld to satisfy associated tax liability

No. of Shares retained

Vanessa Bailey

Chief Risk Officer, NatWest Holdings

36,737

17,267

19,470

Helen Cook

Chief HR Officer

18,001

8,461

9,540

Peter Flavel

Chief Executive Officer, Private Banking

33,084

15,550

17,534

Bruce Fletcher

Chief Risk Officer

44,084

20,720

23,364

Andrew McLaughlin1

CEO, RBS International

22,042

-

22,042

Simon McNamara

Chief Administrative Officer

47,758

22,924

24,834

Les Matheson

CEO, Personal Banking

44,084

21,161

22,923

John-Paul Thwaite

CEO, Commercial Banking

33,063

15,540

17,523

1. The award was granted when the PDMR was resident in Jersey and therefore is taxable in Jersey only and not in the UK. No employer tax withholding is required under Jersey law. The Jersey income tax payable in respect of the vesting of the award will be paid by the PDMR directly to the Jersey tax authority.

 

The market price used to determine the number of Shares withheld to meet associated tax liabilities was £1.409. The above transactions took place outside of a trading venue. Shares retained after payment of associated tax liabilities will be held on behalf of PDMRs and will be released in instalments over a three year period.

 

4. The Company announces that the PDMR set out below has purchased Shares on the date and at the price indicated:-

 

Name of PDMR

Position of PDMR

No. of Shares purchased

Purchase price

Date of transaction

Patrick Flynn

Non-executive director

20,000

£1.476

10 March 2020

 

The transaction took place on the London Stock Exchange (XLON).

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

For further information contact:-

 

RBSG Investor RelationsAlexander HolcroftHead of Investor Relations+44(0)20 7672 1758

 

RBSG Media Relations

+44(0)131 523 4205

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFSRVTIILII
Date   Source Headline
17th Apr 201911:20 amRNSSegmental Reporting Restatement Document
1st Apr 20194:30 pmRNSDirector/PDMR Shareholding
29th Mar 20195:04 pmRNSTotal Voting Rights
27th Mar 20192:05 pmRNSPublication of Final Terms
20th Mar 201910:17 amRNSRBSG pricing of US$2 billion of Senior Notes
19th Mar 20198:30 amRNSMorgan Stanley European Financials Conference
13th Mar 20196:26 pmRNSNotice of Redemption
11th Mar 20193:00 pmRNSDirector/PDMR Shareholding
7th Mar 20194:56 pmRNSForm 8.3 - Findel plc
6th Mar 20192:45 pmRNSForm 8.3 - MedicX Fund Limited
1st Mar 20191:10 pmRNSForm 8.3 - MedicX Fund Limited
1st Mar 201912:01 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSFiling of Annual Report on Form 20-F with US SEC
28th Feb 20192:25 pmRNSDividend Declaration
28th Feb 201912:40 pmRNSTotal Voting Rights
26th Feb 20195:50 pmRNSPublication of Supplementary Prospectus
22nd Feb 201912:51 pmRNSUpdate on NatWest Markets transfer scheme
22nd Feb 201912:00 pmRNSDirector/PDMR Shareholding
15th Feb 20193:00 pmRNSPublication of Supplementary Prospectus
15th Feb 20197:02 amRNSDirectorate Change
15th Feb 20197:01 amRNSAnnual Financial Report
15th Feb 20197:00 amRNSFinal Results
6th Feb 20194:16 pmRNSResult of Meeting
6th Feb 20192:55 pmRNSGM Statement
31st Jan 201911:42 amRNSTotal Voting Rights
29th Jan 20192:55 pmRNSDirector/PDMR Shareholding
25th Jan 20191:27 pmRNSForm 8.3 Disclosure
17th Jan 20194:10 pmRNSNotice of GM
9th Jan 20195:02 pmRNSHolding(s) in Company
31st Dec 20181:13 pmRNSTotal Voting Rights
28th Dec 20184:28 pmRNSDirector/PDMR Shareholding
27th Dec 20184:55 pmRNSDividend Declaration
18th Dec 20183:55 pmRNSDirectorate Change
14th Dec 20186:15 pmRNSRBS welcome credit ratings action by Fitch Ratings
14th Dec 20183:33 pmRNSPublication of a Prospectus
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
6th Dec 20182:16 pmRNSNatWest Markets transfer scheme
30th Nov 20182:30 pmRNSTotal Voting Rights
30th Nov 20181:12 pmRNSDirector/PDMR Shareholding
29th Nov 20184:28 pmRNSDividend Declaration
29th Nov 20184:07 pmRNSNotice of Redemption
29th Nov 201811:34 amRNSNotice of Rdemption
29th Nov 201811:33 amRNSNotice of Redemption
29th Nov 201811:31 amRNSNotice of Redemption
29th Nov 201811:31 amRNSNotice of Redemption
29th Nov 20188:00 amRNSRBS Investor Seminar: Commercial Banking
28th Nov 20185:09 pmRNS2018 Bank of England stress test results
16th Nov 201812:00 pmRNSDirector/PDMR Shareholding
9th Nov 20184:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.